Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidoglycan D,D-transpeptidase MrdA, commonly known as Penicillin-binding protein 2 (PBP2), is an essential enzyme in Escherichia coli responsible for the synthesis and cross-linking of the peptidoglycan layer, specifically during cell elongation (UniProt P0AD65). Encoded by the mrdA gene, it is a Class B high-molecular-mass PBP that functions as a D,D-transpeptidase (PubMed 30995398). PBP2 is critical for maintaining the characteristic rod shape of E. coli; its inhibition or inactivation leads to the formation of spherical cells and eventual bacterial lysis (PubMed 1103132). It is the primary target of the beta-lactam antibiotic mecillinam (amdinocillin), which binds covalently to the active site serine to block enzyme activity (PubMed 3009484). Beyond its catalytic role, PBP2 is part of the elongasome complex and interacts with other proteins like RodA to coordinate cell wall growth (PubMed 12519203). Resistance to drugs targeting PBP2 can arise through mutations in the mrdA gene or through the action of beta-lactamases that degrade the antibiotics before they reach the target (PubMed 31939154).
Covalent inhibition of transpeptidase activity by acylating the active site serine residue (Ser330), preventing peptidoglycan cross-linking and leading to cell wall instability, spherical cell morphology, and lysis (UniProt P0AD65, PubMed 30995398).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan D,D-transpeptidase MrdA (PBP2) (PBP2).